Tranilast for enlarged prostate (medium to large volume)
Part of Kidney & urinary clinical trials.
This trial tests a drug called Tranilast to see if it can improve urinary symptoms caused by an enlarged prostate. It focuses on men with moderate to severe symptoms and a prostate size greater than 40 mL.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 55 and 75 years old.
- Your prostate is larger than 40 mL (about the size of a golf ball or bigger).
- You have urinary symptoms like trouble starting or weak stream, with a symptom score of 8 or higher, or a maximum flow rate less than 15 mL per second.
- You do not have other causes of urinary blockage, like a urethral stricture.
- You do not have major organ problems like liver or kidney issues, and you are not taking the blood thinner warfarin.
- You are not allergic to Tranilast or similar drugs, and you have no history of bladder or prostate cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether tryptophan is safe and can improve urinary symptoms caused by an enlarged prostate (BPH). It focuses on men who have bothersome, stable symptoms and who would normally take tamsulosin.
This trial tests whether a drug called adalimumab (a TNF blocker) can improve symptoms of an enlarged prostate. It is for men aged 45-80 with a large prostate and bothersome urinary symptoms who have not used this type of medication before.
This study tests whether taking tadalafil (at 2.5 mg or 5 mg) along with tamsulosin is better for treating urinary symptoms caused by an enlarged prostate than taking tamsulosin alone. It aims to find the best dose combination to improve your quality of life.
This trial compares two medications, silodosin and tamsulosin, to see which one works better for men with frequent or difficult urination caused by an enlarged prostate. All participants will try both medicines at different times to find the best option.
This trial tests a new device called the FloStent, a small tube placed in the urine channel to help men with an enlarged prostate pee more easily. It's for men who have moderate to severe symptoms and haven't had prostate surgery before.
This trial compares two minimally invasive procedures to relieve urinary symptoms caused by an enlarged prostate. Both treatments aim to open the urethra without major surgery, and the goal is to improve your urine flow and reduce bothersome symptoms.
Hear when a new Prostatic Hypertrophy, Benign trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.